These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12238917)

  • 21. Design, synthesis, and biological evaluation of new cyclic disulfide decapeptides that inhibit the binding of AP-1 to DNA.
    Tsuchida K; Chaki H; Takakura T; Yokotani J; Aikawa Y; Shiozawa S; Gouda H; Hirono S
    J Med Chem; 2004 Aug; 47(17):4239-46. PubMed ID: 15293995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Small molecular probes for G-protein-coupled C5a receptors: conformationally constrained antagonists derived from the C terminus of the human plasma protein C5a.
    Wong AK; Finch AM; Pierens GK; Craik DJ; Taylor SM; Fairlie DP
    J Med Chem; 1998 Aug; 41(18):3417-25. PubMed ID: 9719594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of nonpeptidic urotensin II receptor antagonists by virtual screening based on a pharmacophore model derived from structure-activity relationships and nuclear magnetic resonance studies on urotensin II.
    Flohr S; Kurz M; Kostenis E; Brkovich A; Fournier A; Klabunde T
    J Med Chem; 2002 Apr; 45(9):1799-805. PubMed ID: 11960491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vinyl sulfide cyclized analogues of angiotensin II with high affinity and full agonist activity at the AT(1) receptor.
    Johannesson P; Lindeberg G; Johansson A; Nikiforovich GV; Gogoll A; Synnergren B; Le Grèves M; Nyberg F; Karlén A; Hallberg A
    J Med Chem; 2002 Apr; 45(9):1767-77. PubMed ID: 11960488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis, conformational analysis, and biological studies of urotensin-II lactam analogues.
    Grieco P; Carotenuto A; Patacchini R; Maggi CA; Novellino E; Rovero P
    Bioorg Med Chem; 2002 Dec; 10(12):3731-9. PubMed ID: 12413830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel ligands lacking a positive charge for the delta- and mu-opioid receptors.
    Schiller PW; Berezowska I; Nguyen TM; Schmidt R; Lemieux C; Chung NN; Falcone-Hindley ML; Yao W; Liu J; Iwama S; Smith AB; Hirschmann R
    J Med Chem; 2000 Feb; 43(4):551-9. PubMed ID: 10691681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ring size in cyclic endomorphin-2 analogs modulates receptor binding affinity and selectivity.
    Piekielna J; Kluczyk A; Gentilucci L; Cerlesi MC; Calo' G; Tomböly C; Łapiński K; Janecki T; Janecka A
    Org Biomol Chem; 2015 Jun; 13(21):6039-46. PubMed ID: 25948019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Designing analogues of mini atrial natriuretic peptide based on structural analysis by NMR and restrained molecular dynamics.
    Sugase K; Oyama Y; Kitano K; Iwashita T; Fujiwara T; Akutsu H; Ishiguro M
    J Med Chem; 2002 Feb; 45(4):881-7. PubMed ID: 11831899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unraveling the active conformation of urotensin II.
    Carotenuto A; Grieco P; Campiglia P; Novellino E; Rovero P
    J Med Chem; 2004 Mar; 47(7):1652-61. PubMed ID: 15027856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular dynamics study of disulfide bond influence on properties of an RGD peptide.
    Wang Y; Goh SY; Kuczera K
    J Pept Res; 1999 Feb; 53(2):188-200. PubMed ID: 10195456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Solution structure of a cyclic RGD peptide that inhibits platelet aggregation.
    Jois SD; Tambunan US; Chakrabarti S; Siahaan TJ
    J Biomol Struct Dyn; 1996 Aug; 14(1):1-11. PubMed ID: 8877556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and synthesis of potent and selective alpha(4)beta(7) integrin antagonists.
    Boer J; Gottschling D; Schuster A; Semmrich M; Holzmann B; Kessler H
    J Med Chem; 2001 Aug; 44(16):2586-92. PubMed ID: 11472212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urotensin-II peptidomimetic incorporating a non-reducible 1,5-triazole disulfide bond reveals a pseudo-irreversible covalent binding mechanism to the urotensin G-protein coupled receptor.
    Pacifico S; Kerckhoffs A; Fallow AJ; Foreman RE; Guerrini R; McDonald J; Lambert DG; Jamieson AG
    Org Biomol Chem; 2017 May; 15(21):4704-4710. PubMed ID: 28524918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conformation/activity studies of rationally designed potent anti-adhesive RGD peptides.
    Gurrath M; Müller G; Kessler H; Aumailley M; Timpl R
    Eur J Biochem; 1992 Dec; 210(3):911-21. PubMed ID: 1483474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-activity relationships of a novel series of urotensin II analogues: identification of a urotensin II antagonist.
    Chatenet D; Dubessy C; Boularan C; Scalbert E; Pfeiffer B; Renard P; Lihrmann I; Pacaud P; Tonon MC; Vaudry H; Leprince J
    J Med Chem; 2006 Nov; 49(24):7234-8. PubMed ID: 17125276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nuclear magnetic resonance studies of the binding of captopril and penicillamine by serum albumin.
    Keire DA; Mariappan SV; Peng J; Rabenstein DL
    Biochem Pharmacol; 1993 Sep; 46(6):1059-69. PubMed ID: 8216349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel sst(4)-selective somatostatin (SRIF) agonists. 3. Analogues amenable to radiolabeling.
    Erchegyi J; Waser B; Schaer JC; Cescato R; Brazeau JF; Rivier J; Reubi JC
    J Med Chem; 2003 Dec; 46(26):5597-605. PubMed ID: 14667214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclic beta-casomorphin analogues with mixed mu agonist/delta antagonist properties: synthesis, pharmacological characterization, and conformational aspects.
    Schmidt R; Vogel D; Mrestani-Klaus C; Brandt W; Neubert K; Chung NN; Lemieux C; Schiller PW
    J Med Chem; 1994 Apr; 37(8):1136-44. PubMed ID: 8164255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amino acids that specify structure through hydrophobic clustering and histidine-aromatic interactions lead to biologically active peptidomimetics.
    Graciani NR; Tsang KY; McCutchen SL; Kelly JW
    Bioorg Med Chem; 1994 Sep; 2(9):999-1006. PubMed ID: 7712134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proton n.m.r. investigation of conformational influence of penicillamine residues on the disulfide ring system of opioid receptor selective somatostatin derivatives.
    Sugg EE; Tourwe D; Kazmierski W; Hruby VJ; Van Binst G
    Int J Pept Protein Res; 1988 Feb; 31(2):192-200. PubMed ID: 2896639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.